je.st
news
Tag: treatment
Syngenta launches novel seed treatment insecticide
2013-10-31 22:04:03| Chemicals - Topix.net
Asian news probably added to the bullish atmosphere in the soy complex. As with corn, the persistent rains crossing the Midwest may be diminishing the potential U.S. bean harvest.
Tags: treatment
seed
launches
insecticide
Nalco-Water Treatment and Removal of Mercury Emissions
2013-10-31 16:27:00| Power Technology
Nalco provides innovative, eco-friendly services for water treatment and emission reductions in the power industry. The company has a worldwide client base, providing cost-effective solutions that are safe, reliable and help bring measurable returns
Tags: treatment
removal
mercury
emissions
Anti-Glare Coatings feature anti-microbial treatment.
2013-10-31 13:30:51| Industrial Newsroom - All News for Today
Vueguard® 900 AG and soft touch Vueguard® 400 AG Series anti-glare (AG) coatings are available with anti-microbial (AM) agents. While Vueguard 400 AG-AM is suited for keyboards and other mobile devices, Vueguard 900 AG-AM is suited for medical devices and electronic displays constructed in PC, PMMA, ABS, and other polymeric substrates. Both UV-curable treatments reduce glare and eliminate unwanted reflections by scattering light that strikes matte screen, increasing readability. This story is related to the following:Anti-Glare Screens |
Tags: treatment
feature
coatings
antimicrobial
Cempra, Inc. Receives U.S. Orphan Drug Designation For Taksta For Treatment Of Prosthetic Joint Infections
2013-10-30 05:42:32| drugdiscoveryonline News Articles
Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its drug candidate Taksta™ (CEM-102) for the treatment of prosthetic joint infections (PJI)
Tags: treatment
drug
joint
receives
MIV-247 Has Been Selected As A Candidate Drug And Enters Development For The Treatment Of Neuropathic Pain
2013-10-30 05:30:13| drugdiscoveryonline News Articles
Medivir AB (OMX:MVIR) announced that MIV-247 has been selected as a candidate drug (CD) from its cathepsin S inhibitor project for the treatment of neuropathic pain, and is entering non-clinical development
Tags: the
of
development
selected
Sites : [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] next »